<DOC>
	<DOCNO>NCT00646412</DOCNO>
	<brief_summary>The safety apply A-Part® Gel intra-peritoneally incision order prevent post-surgical adhesion median laparotomy .</brief_summary>
	<brief_title>A-Part® Gel Adhesion Prophylaxis After Major Abdominal Surgery Versus Non-treated Group</brief_title>
	<detailed_description>Primary Objective : • first assessment safety apply A-Part® Gel adhesion prophylaxis major abdominal surgery specific observation two major complication abdominal surgery ( wound heal impairment , and/or postoperative peritonitis ) comparison control group . Secondary Objectives : - To evaluate safety A-Part® Gel compare incidence adverse event treatment group ( special attention anastomosis leakage ) - To explore efficacy A-Part® Gel reduce post-surgical adhesion median laparotomy</detailed_description>
	<mesh_term>Tissue Adhesions</mesh_term>
	<criteria>Patients sex , candidate primary elective median abdominal incision length ≥ 15 cm 2 . Age ≥ 18 year Patients legally capable able understand nature , significance consequence study willing able comply study protocol follow Written inform consent obtain accord international guideline local law . Informed consent document volunteer 's dated signature , also sign dated investigator Patients expect survival time &gt; 12 month For female adult reproductive potential : Negative pregnancy test visit 1 sufficient contraception time write consent least 4 month Patients previous median laparotomy abdominal surgery ( exception : previous laparoscopic appendectomy , cholecystectomy , inguinal hernia repair , gynecological tube sterilisation ) Patients known history adhesion know history peritonitis Patients known sensitivity polyvinylalcohol and/or carboxymethylcellulose Simultaneous participation patient another clinical trial participation clinical trial within last 30 day prior sign Informed consent form Patients ASA &gt; 3 emergency patient ( include severe psychic diesease ) Patients ascites &gt; 200 ml Patients peritoneal carcinosis peritoneal dialysis Patients diagnose peritonitis , intraabdominal abscess intraabdominal infection Patient renal impairment ( Creatinine &gt; 1.3 mg/dl ) Patients systemic immunosuppression ( e.g . hydrocortisone &gt; 50mg daily [ oral/i.v . ] day equivalent dosage ; immunosuppressant like Azathioprin , Mycophenolatmofetil , Ciclosporin , Everolimus , Methotrexat , ect . ) , chemotherapy radiotherapy within last 2 week prior surgery Surgical procedure patient characteristic require insertion 2 intraabdominal drainage Women within pregnancy breastfeed mother woman wish get pregnant within next 4 month surgery woman without sufficient contraceptive care</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>randomize , control , single-blind study</keyword>
	<keyword>Adhesion Prophylaxis</keyword>
	<keyword>Abdominal Surgery</keyword>
	<keyword>Laparotomy , median</keyword>
</DOC>